This presentation by Privium Funds LLC outlines a strategic plan to address insulin supply constraints by leveraging a unique manufacturing process to offer a generic insulin product. The presentation discusses market trends, strategic goals, and the potential for significant cost reductions in insulin pricing. It also highlights the company's business vision, intellectual property scope, and next steps for regulatory approval and market expansion.
documents/EFTA00596368.pdf
{}